Research
Short summaries and evidence ratings for compounds in our catalog. For informational purposes only.
Retatrutide
Next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 2 data showed 24.2% body weight reduction at highest dose.
One of the most clinically significant pipeline compounds in metabolic research.
BPC-157
Synthetic gastric pentadecapeptide widely discussed in soft-tissue healing. Studied in tissue repair, angiogenesis, and mucosal protection models.
Most discussed recovery peptide online, but evidence remains preclinical-heavy.
TB-500
Synthetic fragment related to thymosin beta-4 biology. Studied in tissue repair, cell migration, and angiogenesis.
Biologically plausible repair story, but evidence remains largely preclinical.
GHK-Cu
Copper-binding peptide associated with dermal repair, collagen signaling, and skin-health biology. Over 50 published studies.
Stands out as a plausible regenerative-skin peptide with meaningful mechanistic support.
CJC-1295 / Ipamorelin
Popular growth-hormone-axis protocol combining a long-acting GHRH analog with a selective ghrelin-receptor agonist.
Cleaner theoretical rationale among secretagogue protocols, but evidence is endocrine rather than clinical.
Ipamorelin
One of the best-known selective GH secretagogues. Stimulates GH release without elevating cortisol or prolactin.
More mechanistically coherent and selective than many secretagogues.
Sermorelin
Classic growth-hormone-releasing hormone analog used to stimulate endogenous GH secretion. Long clinical history.
One of the cleaner physiologic stories among GH-axis peptides.
Tesamorelin
One of the strongest clinically supported GH-axis agents. FDA-approved for HIV-associated lipodystrophy.
One of the most clinically credible peptides in the GH-axis category.
PT-141
Melanocortin agonist (bremelanotide) with FDA-approved analog Vyleesi. Targets sexual function via CNS pathways.
Stands out as a peptide with real clinical-development depth and FDA precedent.
NAD+
Central to mitochondrial energy production and cellular repair. Foundational to aging biology and metabolic research.
NAD+ is foundational to energy and aging biology. Well-established scientific basis.
MOTS-C
Mitochondria-derived peptide. One of the most scientifically interesting compounds in metabolic and exercise mimetic research.
Intellectually serious peptide in metabolic science. Translational candidate, not clinical standard.
Thymosin Alpha-1
Immunomodulatory peptide with deeper clinical and scientific literature than many peptides in this category.
Legitimate immune-regulation peptide with real scientific depth.
Epithalon
Synthetic tetrapeptide studied for proposed effects on telomerase activation and cellular aging biology.
Legitimate topic in aging-biology education, but not a clinically settled therapy.
Selank
Synthetic peptide analog linked to anxiolytic and neurobehavioral research. Tuftsin-derived.
Coherent experimental niche in stress and anxiety signaling.
Semax
Synthetic ACTH fragment associated with neuroprotection, BDNF expression, and cognitive function research.
One of the more serious neuroactive peptides scientifically.
LL-37
Human antimicrobial peptide with a legitimate role in innate immunity and host defense biology.
One of the more biologically grounded immune peptides, but clinical translation is complex.
KPV
Tripeptide fragment from alpha-MSH. Studied in inflammation, gut health, and immune modulation.
More coherent anti-inflammatory niche than many fringe peptides, but still mostly experimental.
Hexarelin
Growth-hormone secretagogue from the GHRP family with a long history in endocrine research.
One of the more potent classic GHRPs in the published literature.
Oxytocin
Hypothalamic neuropeptide hormone with well-established roles in bonding, parturition, and social signaling.
Biologically real and important, but not simple as a therapeutic.
DSIP
Delta sleep-inducing peptide. One of the older neuropeptides in the sleep-optimization research space.
Scientifically interesting but clinically underdeveloped.
AOD 9604
Synthetic fragment of human growth hormone developed to explore lipolytic and anti-obesity effects.
More human history than many experimental peptides, but benefit signal appears modest.
Melanotan II
Experimental melanocortin agonist studied for tanning, pigmentation, and sexual-arousal pathways.
Real melanocortin biology, but experimental and not a routine approved therapy.
Somatropin
Recombinant human growth hormone. The benchmark against which GH secretagogues and fragments are compared.
The reference standard for GH therapy. Well-established clinical use.
Disclaimer: Research summaries are provided for informational purposes only. All compounds are sold for research use only, not for human or veterinary consumption. Evidence ratings reflect the current state of published peer-reviewed literature and do not constitute medical advice or endorsement for therapeutic use.